SCHEMBL1238045

SCHEMBL1238045

OC(CC(F)(F)F)OC(O)CC(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13670116 0.87 TSHR (0.62) HTTTSHR
SCHEMBL21246430 0.77
SCHEMBL23631743 0.71 HTT (0.37) HTT
SCHEMBL8027929 0.69 HTT (0.33) HTT
SCHEMBL8617011 0.69 HTT (0.33) HTT
SCHEMBL10291272 0.69
SCHEMBL891753 0.67
SCHEMBL1623537 0.65 OR51E2 (0.46) HTTTSHR
SCHEMBL2862248 0.65
SCHEMBL9319804 0.65 CETP (0.50) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247786-A1 Process For Producing 3,3,3-Trifluoropropionic Acid CENTRAL GLASS COMPANY, LIMITED (JP) 2009-10-01 US claimed
EP-1950191-A1 PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID Central Glass Co., Ltd. (JP) 2008-07-30 EP claimed
US-7880033-B2 hydrolyzing benzyl vinyl ether derivative in presence of an acid catalyst Lewis acid or H2SO4 thereby obtaining 3,3,3-trifluoropropionaldehy, oxidizing intermediate with HNO3 to produce 3,3,3-triluoropropionic acid; cost efficiency CENTRAL GLASS COMPANY, LIMITED (JP) 2011-02-01 US disclosed
US-7880033-B2 hydrolyzing benzyl vinyl ether derivative in presence of an acid catalyst Lewis acid or H2SO4 thereby obtaining 3,3,3-trifluoropropionaldehy, oxidizing intermediate with HNO3 to produce 3,3,3-triluoropropionic acid; cost efficiency CENTRAL GLASS COMPANY, LIMITED (JP) 2011-02-01 US disclosed
US-7880033-B2 hydrolyzing benzyl vinyl ether derivative in presence of an acid catalyst Lewis acid or H2SO4 thereby obtaining 3,3,3-trifluoropropionaldehy, oxidizing intermediate with HNO3 to produce 3,3,3-triluoropropionic acid; cost efficiency CENTRAL GLASS COMPANY, LIMITED (JP) 2011-02-01 US disclosed
US-20090247786-A1 Process For Producing 3,3,3-Trifluoropropionic Acid CENTRAL GLASS COMPANY, LIMITED (JP) 2009-10-01 US disclosed
US-20090247786-A1 Process For Producing 3,3,3-Trifluoropropionic Acid CENTRAL GLASS COMPANY, LIMITED (JP) 2009-10-01 US disclosed
US-20090247786-A1 Process For Producing 3,3,3-Trifluoropropionic Acid CENTRAL GLASS COMPANY, LIMITED (JP) 2009-10-01 US disclosed
EP-1950191-A1 PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID Central Glass Co., Ltd. (JP) 2008-07-30 EP disclosed
EP-1950191-A1 PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID Central Glass Co., Ltd. (JP) 2008-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247786-A1 Process For Producing 3,3,3-Trifluoropropionic Acid HAO2, ALDH1A3, AOX1 HTT 3972/4885TSHR 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.